Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

Recruiting now · Not applicable

Conditions studied: Type 1 Diabetes, Type2diabetes

In brief

This is a single-centre, multiple cohort, open study.

Key facts

Study ID

NCT06272136

Run by

Liom Health AG

People needed

80

Starts

2024-02-23

Expected to finish

2025-07-31

Last updated by the study team

2024-10-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female trial participant with clinically diagnosed type 1 or type 2 diabetes for at least 1 year.
• Age between 18 and 65 years, both inclusive.
• Treated with insulin and/or oral antidiabetic drugs (OADs; type 2 only), multiple dosing insulin therapy (MDI), continuous subcutaneous insulin infusion (CSII) or a hybrid closed loop system.

You may not qualify if…

• Known or suspected hypersensitivity to any of the components of the Liom Clinical Demo 2.0.
• Trial participant with any injury, infection, atypical skin condition (e.g., hyperkeratosis, hyperpigmentation) of or tattoo on the wrists.
• Presence or history of a cardiovascular disease including stable and unstable angina pectoris, myocardial infarction, transient ischaemic attack, stroke, cardiac decompensation, clinically significant arrhythmias or clinically significant conduction disorders.

Where it is running

• Profil for Stoffwechselforschung GmbH — Neuss, Nordrhein-Westfallen, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.